Q: Hi, what's your opinion on Medical Facilities potential? It also has a decent dividend.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Thoughts on QIPT’s recent quarterly financials please
Thanks
Thanks
Q: This is all hypothetical of course....
I bought a chunk of TRIL today...and arb play. Should I be worried about exchange rate friction? The take out price is US$18.50. As of today, that works out to about C$23.30.
Can currency movements wipe out the 5% gain I expect?
I bought a chunk of TRIL today...and arb play. Should I be worried about exchange rate friction? The take out price is US$18.50. As of today, that works out to about C$23.30.
Can currency movements wipe out the 5% gain I expect?
Q: Aurinia appears to have increasing revenue now and the question is how fast does it ramp up to increase the share price, I believe they have the goods so if this is true considering market capitalization and potential where could we see the share price when looking at the analyst estimates? There easily could be a buy out of this company so the question is after what upcoming event(s) would be the best timing for this. If they go it alone what does your experience tell you and can you put percentages on a guesstimate? Do you have any relevant Bloomberg script numbers? Also, do you think the company is currently worth the risk at the $13.64 a share. Your help is appreciated.
Q: Endo Pharma tanked on Friday (down one-third) after announcing the hiring of a Restructuring Advisor. Do you think they will survive?
Of course, this revives the "will Knight ger Paladin" question.
I have always thought Endo would never sell to Knight because they would be embarrassed after paying so much for the company to Goodman and Co...
I guess it's now if ever...
Of course, this revives the "will Knight ger Paladin" question.
I have always thought Endo would never sell to Knight because they would be embarrassed after paying so much for the company to Goodman and Co...
I guess it's now if ever...
Q: Hi, we have a small <1% holding in Well Health. Stock does not seem to gain traction over $7-$8 level, despite great news time to time, over past 2 years. I know, you have a lot of conviction in the company, based on the CEO's past record. Even the last news of their majority share holder and HK business tycoon, snapping company's shares @ $9.50, during a private placement. My question is that is the stock worth holding due to its growth potential ( despite not so impressive price movement ) and if so, do you believe, it could reach $9-$10 in next 1-2 years. Or, we should be patient, expecting a buyer, at some point in the future.
Thank You
Thank You
Q: Have followed this stock for years and never owned it I saw the G& Mail article on the recent executive change. Do you expect this event significant enough to purchase the stock, thinking that the pace of acquisitions will pick up ? Thanks Derek
Q: There is an in depth article on Knight, Samira Sakhia and Jonathan Goodman in yesterday's Globe and Mail. Would you post it for me? Not sure how:).
Very important info for Knight faithful (like me!).
Very important info for Knight faithful (like me!).
Q: Watched a very interesting interview with an analyst on BNN yesterday making the case for therapeutics as the way forward for battling new Covid variants (as opposed to MRNA booster shots). Made interesting points and suggested a few stocks. Two are very small but SRNE is a reasonably sized Co. What does the book look like for this one?
TIA
TIA
Q: Would you consider REGN to be a buy at this level or is there a better choice in the sector?
Q: I finally have a small gain on Gilead. Would you continue to hold or switch to some other stock like ABBV or ZTS or some other pharma or biotech stock you like? Thank you. Cheers
Q: Which stock has the most torque AND or WELL.I have a position in WELL.Wondering if I should add to WELL or start a new position in AND.This would be for a long term hold.
Q: Hi Folks,
in my RRSP account I have PFE and ABBV - I am thinking of selling some PFE and adding to ABBV to bring each weighing to 10%. Currently 14% and 7%. Would you recommend ABBV over PFE at this time?
Thanks
in my RRSP account I have PFE and ABBV - I am thinking of selling some PFE and adding to ABBV to bring each weighing to 10%. Currently 14% and 7%. Would you recommend ABBV over PFE at this time?
Thanks
Q: I've just started to look into GUD and I'm trying to understand why the shares have been trading down since 2017. From what I can see, earnings and revenue have been climbing, they've beaten EPS estimates the last 5 quarters, insiders are buying, the company is buying back shares, management has a good track record....what is the bull thesis or what am I missing?
- Illumina Inc. (ILMN)
- Telo Genomics Corp. (TELO)
- Invitae Corporation (NVTA)
- Editas Medicine Inc. (EDIT)
- CRISPR Therapeutics AG (CRSP)
- ARK Genomic Revolution ETF (ARKG)
Q: The genome space seems to have taken a hit and I'd like to add some to my portfolio. Can you give me 3 to 5 Canadian or US stocks going forward that you believe have the highest potential of gains( I realise this would also be subject to the most risk) for a 5 plus year hold.
Also 3 to 5 stocks from Canada or US that you feel should be held for long term exposure.
Thank you.
Also 3 to 5 stocks from Canada or US that you feel should be held for long term exposure.
Thank you.
- Intuitive Surgical Inc. (ISRG)
- AbbVie Inc. (ABBV)
- Johnson & Johnson (JNJ)
- Medtronic plc. (MDT)
- Merck & Company Inc. (MRK)
- Pfizer Inc. (PFE)
- Stryker Corporation (SYK)
- Veeva Systems Inc. Class A (VEEV)
- WELL Health Technologies Corp. (WELL)
- DexCom Inc. (DXCM)
- Curaleaf Holdings Inc. Subordinate Voting Shares (CURA)
- CareRx Corporation (CRRX)
Q: Hello Peter and Staff
So I am a slow learner and a bad listener.....in order to add AND to my health care basket, Chartwell is gone.......I did not feel like adding $ for $ so have some of CSH proceeds left to top up a position or 2 in my basket....Please list 1, 2 ,3 in priority of your preferences above and if you see any you would not advise be kept, please say so and why.
Thanks for all you do
Dennis
So I am a slow learner and a bad listener.....in order to add AND to my health care basket, Chartwell is gone.......I did not feel like adding $ for $ so have some of CSH proceeds left to top up a position or 2 in my basket....Please list 1, 2 ,3 in priority of your preferences above and if you see any you would not advise be kept, please say so and why.
Thanks for all you do
Dennis
- Teladoc Health Inc. (TDOC)
- Acadia Healthcare Company Inc. (ACHC)
- Intra-Cellular Therapies Inc. (ITCI)
- Magellan Health Inc. (MGLN)
- CloudMD Software & Services Inc. (DOC)
Q: Following the pandemic there is a significant increase in mental health issues. Would you suggest any company or companies which are helping in addressing this issue and which you think have a good opportunity to grow. Thanks.
Regards,
Shyam
Regards,
Shyam
- AbbVie Inc. (ABBV)
- The Cigna Group (CI)
- Knight Therapeutics Inc. (GUD)
- WELL Health Technologies Corp. (WELL)
- MEDIFAST INC (MED)
Q: I would like to double my Health sector % as recommended by Portfolio Analytics. I could also increase US portion of my portfolio but either Can or US is fine.
Current holdings and percentage of total portfolio are:
GUD (.75%), WELL (2.85%), ABBV (.81%)
Could increase existing holdings but have also been looking at US stocks CI and MED.
Your thoughts on approach and recommendations, including additions/deletions/other equities I have not mentioned would be appreciated. Dividend is not essential.
As always, many thanks.
Current holdings and percentage of total portfolio are:
GUD (.75%), WELL (2.85%), ABBV (.81%)
Could increase existing holdings but have also been looking at US stocks CI and MED.
Your thoughts on approach and recommendations, including additions/deletions/other equities I have not mentioned would be appreciated. Dividend is not essential.
As always, many thanks.
Q: Cipher had pretty good numbers in the 2nd q. This company may have turned the corner. The new ceo ( joined in 2019) Mull is a smart dude who made a lot of shareholders money on CML Healthcare. This one may be one to watch.
Q: did you have a chance to listen to the cc to see what accounts for the quarter results? Thx